In the last ten years, there have been six studies (11–16) that have reported gene mutations in thymic carcinomas, including those in EGFR exons 18–21, HER-2 exons 19–20, Kras exon 2 and KIT exons 9, 11, 13 and 17. Here, ERBB2 is linked to thymic carcinoma.